Breathing in medicines for ARDS on a ventilator
Part of Lungs & breathing clinical trials.
This study tests whether breathing in a mix of furosemide, heparin, and salt water (hypertonic saline) through a nebulizer can help adults with ARDS who are on a ventilator. It aims to see if these medicines can reduce lung inflammation and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the ICU and have been on a breathing machine for less than 7 days
- You have been diagnosed with ARDS within the last 24 hours
- You are not pregnant
- You do not have a known allergy to furosemide or heparin
- You do not have severe kidney, liver, or bleeding problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to adjust the amount of air given by the ventilator to people with a severe lung injury called ARDS. The goal is to see if a specific breathing strategy can help protect the lungs and improve recovery.
This trial tests whether delivering medication through a ventilator mask (aerosol therapy) can help adults with ARDS breathe better. It is designed for patients who are already on a breathing machine.
This trial tests a special breathing machine strategy that uses pressure measurements from a small tube in your esophagus (food pipe) to protect your heart's right side while treating ARDS caused by pneumonia. It may help if you have severe lung failure and need a ventilator.
This study compares a more careful ventilation approach for people with severe lung breathing failure (ARDS). It aims to improve outcomes by using a specific strategy for how the ventilator controls breathing.
This study looks at how the level of pressure from a breathing machine affects blood flow back to the heart in people with severe lung injury (ARDS). It may help doctors find the best settings to protect your heart while helping your lungs.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
Hear when a new Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.